Brief: Cosmo Pharmaceuticals Announces Amendment Of Its Investment Agreement With Acacia

Cosmo NV

15/12/2020 06:04

Dec 15 (Reuters) - Cosmo Pharmaceuticals NV  COPN.S :
    * COSMO PHARMACEUTICALS ANNOUNCES AMENDMENT OF ITS
INVESTMENT
AGREEMENT WITH ACACIA
    * ON 14 DECEMBER 2020, ACACIA PHARMA GROUP PLC AND COSMO
ENTERED
INTO AN AMENDMENT AGREEMENT
    * PAYMENT WILL BE SETTLED BY COMPANY ISSUING NEW ORDINARY
SHARES
IN SHARE CAPITAL OF COMPANY TO COSMO, AT AN ISSUE PRICE OF EUR
2.38 EACH
    * NEW ORDINARY SHARES WILL RANK PARI PASSU IN ALL RESPECTS
WITH
COMPANY'S EXISTING ORDINARY SHARES IN ISSUE
    * FOLLOWING RECEIPT OF NEW ORDINARY SHARES, COSMO'S STAKE IN
ACACIA WILL INCREASE FROM 20.52% TO APPROX. 21.88%.
    * THIS BRINGS TOTAL MILESTONES RECEIVED BY COSMO IN 2020 AS
A
RESULT OF SUBLICENCE OF ITS BYFAVOTM US RIGHTS TO ACACIA TO EUR
45 MILLION.

Source text for Eikon:  ID:nTEN8e2qaa 
Further company coverage:  COPN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))